Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Treatment for Patients With Metastatic Thyroid Cancer

This study has been completed.
Sponsor:
Collaborator:
Pfizer
Information provided by:
University of Michigan Cancer Center
ClinicalTrials.gov Identifier:
NCT00176748
First received: September 9, 2005
Last updated: January 14, 2010
Last verified: January 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2009
  Primary Completion Date: August 2006 (Final data collection date for primary outcome measure)